Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. NB120848

anti-pan Cytokeratin, Clone: 5D3 & LP34, Novus Biologicals™
SDP

Catalog No. NB120848 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
6 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB120848 6 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB120848 Supplier Novus Biologicals Supplier No. NBP244175AF532
Add to Cart
Add to Cart

Description

Mouse Monoclonal Antibody

GSTM3 Monoclonal specifically detects GSTM3 in Human, Mouse samples. It is validated for Western Blot, ELISA, Immunohistochemistry.

Specifications

Antigen pan Cytokeratin
Applications Immunohistochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin)
Classification Monoclonal
Clone 5D3 & LP34
Conjugate Unconjugated
Host Species Mouse
Immunogen Cytokeratins from human breast carcinoma cell line MCF-7 and
Quantity 6 mL
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 3848
Test Specificity This is a cocktail of two different clones; 5D3 and LP53. This stains cytokeratin 5,6,8 and 18.This has been designed for a broad spectrum screening of cytokeratins.It stains carcinomas of simple and squamous origin. Cross-reacts with Human. Not yet tested in other species.
Target Species Human
Form Purified
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.